First City Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-4,030
Closed -$233K – 169
2023
Q4
$233K Hold
4,030
– – 0.14% 151
2023
Q3
$213K Hold
4,030
– – 0.13% 155
2023
Q2
$218K Hold
4,030
– – 0.13% 158
2023
Q1
$210K Buy
+4,030
New +$190K 0.12% 158
2020
Q4
– Sell
-8,060
Closed -$327K – 166
2020
Q3
$327K Buy
+8,060
New +$311K 0.12% 147
2016
Q2
– Sell
-4,030
Closed -$75.8K – 186
2016
Q1
$75.8K Hold
4,030
– – 0.05% 226
2015
Q4
$74.3K Hold
4,030
– – 0.05% 241
2015
Q3
$66.1K Hold
4,030
– – 0.05% 255
2015
Q2
$71.3K Hold
4,030
– – 0.05% 250
2015
Q1
$71.5K Hold
4,030
– – 0.05% 238
2014
Q4
$53.4K Buy
+4,030
New +$51.5K 0.04% 272
2014
Q3
– Sell
-4,030
Closed -$51.5K – 626
2014
Q2
$51.5K Hold
4,030
– – 0.04% 278
2014
Q1
$54.5K Buy
+4,030
New +$52.9K 0.04% 265

Other funds holding BSX

First City Capital Management's BSX Position: Q1 2024 in Review

First City Capital Management sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 4,030 shares — an estimated $233K sold.

First City Capital Management first reported a position in BSX in Q1 2014 and held it in 13 quarters. The position peaked at $327K in Q3 2020. 1,226 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • First City Capital Management reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • First City Capital Management sold 4,030 Boston Scientific shares in Q1 2024, an estimated $233K.
  • First City Capital Management first reported a position in Boston Scientific in Q1 2014 and held it in 13 quarters.
  • First City Capital Management's Boston Scientific position peaked at $327K in Q3 2020.
  • 1,226 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on First City Capital Management's 13F filing for Q1 2024, filed 22 May 2024.